| Trial ID: | L1213 |
| Source ID: | NCT02338635
|
| Associated Drug: |
Ursodeoxycholic Acid
|
| Title: |
Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-Stage Kidney Disease
|
| Interventions: |
DRUG: Ursodeoxycholic Acid
|
| Outcome Measures: |
Primary: Peritoneal membrane function, Changes in peritoneal membrane function (Δ D/Pcreatinine, ΔD/Purea) with peritoneal equilibrium test, 6 months | Secondary: Residula renal function, Changes in estimated GFR, 6 months|Epithelial to Mesenchymal Transition, EMT, Phenotypic changes of Mesothelial cells, 6 months|Oxydative stress, Measurement of GSH/GSSG, 8-OHdG, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Ewha Womans University
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
55
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2015-07
|
| Completion Date: |
2018-01
|
| Results First Posted: |
|
| Last Update Posted: |
2015-05-15
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02338635
|
